• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于1950年至1990年间血清胆固醇与缺血性心脏病的生态学研究。

An ecological study of serum cholesterol and ischaemic heart disease between 1950 and 1990.

作者信息

Law M R, Wald N J

机构信息

Department of Environmental and Preventive Medicine, Wolfson Institute of Preventive Medicine, Medical College of St Bartholomew's Hospital, London, UK.

出版信息

Eur J Clin Nutr. 1994 May;48(5):305-25.

PMID:8055847
Abstract

OBJECTIVE

(i) To carry out a quantitative analysis of the average serum cholesterol levels in different countries in relationship to the ischaemic heart disease (IHD) mortality in these countries. (ii) To examine changes in serum cholesterol levels over time in different countries.

DESIGN

Analysis of published surveys measuring average serum cholesterol in specified communities in different countries.

SETTING

The original cholesterol surveys were mainly in occupational and residential settings.

RESULTS

Survey data allowed estimation of average serum cholesterol levels during specified time periods for 17 countries; estimates in men aged 40-59 years varied from 3.8 mmol/l (rural China) to 7.0 mmol/l (Finland). Variation in serum cholesterol accounted for 80% of the tenfold range in risk of IHD across countries. A difference in total (or LDL) cholesterol of 0.6 mmol/l between countries was associated with an average difference in IHD mortality of 37% at age 55-64 years. Repeat surveys showed that serum cholesterol reductions of the order of 0.6 mmol/l have occurred in some communities over about 5-10 years.

CONCLUSIONS

Variation in serum cholesterol explains four-fifths of the geographical variation in IHD mortality. Reductions in cholesterol of about 0.6 mmol/l (10%) have been achieved in some Western communities or countries over periods of a few years, a change that is associated with a decrease in IHD mortality of over one-third.

摘要

目的

(i)对不同国家的平均血清胆固醇水平与这些国家的缺血性心脏病(IHD)死亡率之间的关系进行定量分析。(ii)研究不同国家血清胆固醇水平随时间的变化。

设计

对在不同国家特定社区测量平均血清胆固醇的已发表调查进行分析。

背景

最初的胆固醇调查主要在职业和居住环境中进行。

结果

调查数据使得能够估计17个国家在特定时间段内的平均血清胆固醇水平;40 - 59岁男性的估计值从3.8 mmol/l(中国农村)到7.0 mmol/l(芬兰)不等。血清胆固醇的差异占各国IHD风险十倍范围的80%。各国之间总胆固醇(或低密度脂蛋白胆固醇)相差0.6 mmol/l,与55 - 64岁年龄段IHD死亡率平均相差37%相关。重复调查显示,在大约5 - 10年的时间里,一些社区的血清胆固醇水平降低了约0.6 mmol/l。

结论

血清胆固醇的差异解释了IHD死亡率地域差异的五分之四。在一些西方社区或国家,几年内实现了胆固醇降低约0.6 mmol/l(10%),这一变化与IHD死亡率降低超过三分之一相关。

相似文献

1
An ecological study of serum cholesterol and ischaemic heart disease between 1950 and 1990.一项关于1950年至1990年间血清胆固醇与缺血性心脏病的生态学研究。
Eur J Clin Nutr. 1994 May;48(5):305-25.
2
[Is the recent decrease in cholesterolemia in the Czech Republic convincing evidence?].[捷克共和国近期胆固醇血症的下降是令人信服的证据吗?]
Cas Lek Cesk. 1996 Sep 18;135(18):589-93.
3
Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data.总血清胆固醇水平与作为年龄函数的死亡风险。一项基于弗雷明汉数据的报告。
Arch Intern Med. 1993 May 10;153(9):1065-73.
4
Trends and determinants of ischaemic heart disease mortality in Finland: with special reference to a possible levelling off in the early 1980s.芬兰缺血性心脏病死亡率的趋势及决定因素:特别提及20世纪80年代初可能出现的趋于平稳态势。
Int J Epidemiol. 1989;18(3 Suppl 1):S109-17.
5
Lifetime risk of coronary heart disease by cholesterol levels at selected ages.特定年龄时不同胆固醇水平下冠心病的终生风险。
Arch Intern Med. 2003 Sep 8;163(16):1966-72. doi: 10.1001/archinte.163.16.1966.
6
The relationship of age, blood pressure, serum cholesterol and smoking habits with the risk of typical and atypical coronary heart disease death in the European cohorts of the Seven Countries Study.七国研究欧洲队列中年龄、血压、血清胆固醇和吸烟习惯与典型和非典型冠心病死亡风险的关系。
Int J Cardiol. 2006 Jan 13;106(2):157-63. doi: 10.1016/j.ijcard.2004.12.092.
7
A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.老年人血脂水平与冠心病的长期随访研究
Chin Med J (Engl). 2004 Feb;117(2):163-7.
8
Contribution of changes in risk factors to the decline of coronary heart disease mortality in Australia over three decades.三十年间危险因素变化对澳大利亚冠心病死亡率下降的作用。
Eur J Cardiovasc Prev Rehabil. 2006 Oct;13(5):760-8. doi: 10.1097/01.hjr.0000220581.42387.d4.
9
Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.冠心病男性患者弥漫性动脉粥样硬化的相关因素及后果。退伍军人事务部高密度脂蛋白干预试验研究组。
Arch Intern Med. 1996 Jun 10;156(11):1181-8.
10
Twenty-year trends in serum cholesterol, hypercholesterolemia, and cholesterol medication use: the Minnesota Heart Survey, 1980-1982 to 2000-2002.1980 - 1982年至2000 - 2002年明尼苏达心脏调查:血清胆固醇、高胆固醇血症及胆固醇药物使用情况的20年趋势
Circulation. 2005 Dec 20;112(25):3884-91. doi: 10.1161/CIRCULATIONAHA.105.549857. Epub 2005 Dec 12.

引用本文的文献

1
The association between anthropometric indices and ischemic heart disease: a large-scale cross-sectional study on the Iranian population.人体测量指数与缺血性心脏病的关系:伊朗人群的大规模横断面研究。
Sci Rep. 2024 Aug 15;14(1):18950. doi: 10.1038/s41598-024-54148-z.
2
Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).血脂控制不理想:来自非干预性俄罗斯中央调查血脂异常治疗不足 II 期研究(CEPHEUS II)的结果。
Cardiovasc Diabetol. 2017 Dec 16;16(1):158. doi: 10.1186/s12933-017-0641-4.
3
Changes in mean serum lipids among adults in Germany: results from National Health Surveys 1997-99 and 2008-11.
德国成年人血清脂质均值的变化:1997 - 1999年及2008 - 2011年国民健康调查结果
BMC Public Health. 2016 Mar 8;16:240. doi: 10.1186/s12889-016-2826-2.
4
How low should we target the LDL goal to improve survival for acute coronary syndrome patients in Hong Kong?为了提高香港急性冠状动脉综合征患者的生存率,我们应将低密度脂蛋白目标设定多低?
BMC Cardiovasc Disord. 2015 Oct 7;15:117. doi: 10.1186/s12872-015-0117-y.
5
Nonstatin Low-Density Lipoprotein-Lowering Therapy and Cardiovascular Risk Reduction-Statement From ATVB Council.非他汀类药物降低低密度脂蛋白胆固醇治疗与心血管风险降低——ATVB 理事会声明。
Arterioscler Thromb Vasc Biol. 2015 Nov;35(11):2269-80. doi: 10.1161/ATVBAHA.115.306442. Epub 2015 Sep 16.
6
Centralized Pan-Middle East Survey on the Under-Treatment of Hypercholesterolemia: Results from the CEPHEUS Study in Egypt.中东地区高胆固醇血症治疗不足集中调查:埃及CEPHEUS研究结果
Cardiol Ther. 2014 Dec;3(1-2):27-40. doi: 10.1007/s40119-014-0031-x. Epub 2014 Nov 18.
7
Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia.比较首发精神分裂症患者使用齐拉西酮与奥氮平治疗的代谢效应。
Psychopharmacology (Berl). 2013 Feb;225(3):627-35. doi: 10.1007/s00213-012-2850-6. Epub 2012 Aug 28.
8
CEPHEUS SA: a South African survey on the undertreatment of hypercholesterolaemia.仙王座有限公司:一项关于南非高胆固醇血症治疗不足的调查。
Cardiovasc J Afr. 2011 Sep-Oct;22(5):234-40. doi: 10.5830/CVJA-2011-044. Epub 2011 Sep 15.
9
Subjects with molecularly defined familial hypercholesterolemia or familial defective apoB-100 are not being adequately treated.具有分子定义的家族性高胆固醇血症或家族性载脂蛋白 B-100 缺陷的患者未得到充分治疗。
PLoS One. 2011 Feb 18;6(2):e16721. doi: 10.1371/journal.pone.0016721.
10
A gene score of nine LDL and HDL regulating genes is associated with fluvastatin-induced cholesterol changes in women.九种 LDL 和 HDL 调节基因的基因评分与女性使用氟伐他汀后胆固醇的变化相关。
J Lipid Res. 2010 Mar;51(3):625-34. doi: 10.1194/jlr.P001792. Epub 2009 Sep 22.